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Abstract
BACKGROUND & AIMS—Heme oxygenase-1 (HO-1) and its metabolic by-product, carbon
monoxide (CO), protect against intestinal inflammation in experimental models of colitis, but little
is known about their intestinal immune mechanisms. We investigated the interactions among CO,
HO-1, and the enteric microbiota in mice and zebrafish.
METHODS—Germ-free, wild-type, and Il10−/− mice and germ free zebrafish embryos were
colonized with pathogen-free (SPF). Germ-free or SPF-raised wild-type and Il10−/− mice were
given intraperitoneal injections of cobalt protoporphyrin (CoPP), which upregulates HO-1, the CO
releasing molecule ALF186, or saline (control). Colitis was induced in wild-type mice housed in
SPF conditions by infection with S. typhimurium.
RESULTS—In colons of germ-free, wild-type mice, SPF microbiota induced production of HO-1
via activation of Nrf2–, IL-10–, and toll-like receptor–dependent pathways; similar observations
were made in zebrafish. SPF microbiota did not induce HO-1 in colons of germ-free Il10−/− mice.
Administration of CoPP to Il10−/− mice before transition from germ-free to SPF conditions
reduced their development of colitis. In Il10−/− mice, CO and CoPP reduced levels of enteric
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bacterial genomic DNA in mesenteric lymph nodes (MLN). In mice with S. typhimurium-induced
enterocolitis, CoPP reduced the numbers of live S. typhimurium recovered from the lamina
propria, MLN, spleen, and liver. Knockdown of HO-1 in mouse macrophages impaired their
bactericidal activity against E. coli, E. faecalis, and S. typhimurium, whereas exposure to CO or
overexpression of HO-1 increased their bactericidal activity. HO-1 induction and CO increased
acidification of phagolysosomes.
CONCLUSIONS—Colonic HO-1 prevents colonic inflammation in mice. HO-1 is induced by
the enteric microbiota and its homeostatic function is mediated, in part, by promoting bactericidal
activities of macrophages.
Keywords
mouse model; IBD; ulcerative colitis; anti-inflammatory agent
INTRODUCTION
The pathogenesis of the human inflammatory bowel diseases (IBD) involves complex
interactions between genetic, immunologic and environmental factors1. The role of the
environment in altering the course of IBD is exemplified by the epidemiological observation
that cigarette smoking is protective against the development of ulcerative colitis2. However,
factors that contribute to the protection from smoking remain unclear. Carbon monoxide
(CO), a major component of cigarette smoke, has anti-inflammatory effects in numerous
experimental models of inflammation3. Mammalian cells generate CO endogenously as a
product of heme degradation by the heme oxygenase (HO) enzymes, of which, heme
oxygenase-1 (HO-1) plays a homeostatic role in host defense and inflammation4. Our group
previously demonstrated that CO ameliorates active inflammation in two models of chronic
IBD, through mechanisms involving induction of HO-15, 6.
Consequently, we sought to further determine mechanisms through which CO and HO-1
maintain intestinal homeostasis. The human IBDs have been linked to genetic defects in
innate immune responses to the enteric microbiota1. In this study, we show that the enteric
microbiota induce colonic expression of HO-1 in WT but not colitis-prone Il10−/− mice.
Pharmacologic induction of HO-1 protects Il10−/− mice from microbiota induced colitis
when transitioned from germ free (GF) to conventional conditions. Induction of HO-1 by the
microbiota represents a pathway conserved among diverse vertebrate hosts, as similar
mechanisms were demonstrated in zebrafish. Moreover, HO-1 derived CO enhances
macrophage bactericidal activity and bacterial clearance in vivo. Together, these
experiments highlight the importance of HO-1 and CO in the maintenance of intestinal
homeostasis through augmented bacterial clearance. HO-1, with pleiotropic anti-
inflammatory effects, is a potential therapeutic molecule of interest in the human IBDs.
RESULTS
The enteric microbiota induce colonic HO-1 in vivo
To determine whether the enteric microbiota regulate colonic HO-1 gene (Hmox1)
expression, WT and colitis-prone Il10−/− mice raised germ-free (GF) were colonized with
specific pathogen free (SPF) enteric microbiota (conventionalized, CNV). WT but not
Il10−/− mice demonstrated increased colonic Hmox1 expression after colonization (Figure
1A). Increased colonic HO-1 protein by Western blot was detected in WT but not Il10−/−
mice 3, 7 and 14 days after colonization (Figure 1B). This finding was confirmed by
immunohistochemical staining for HO-1 in GF and CNV mice (Supplemental Figure 1).
Attenuated colonic HO-1 correlated with the development of colonic inflammation in
Onyiah et al. Page 2













Il10−/− mice 14 days after colonization (Figure 1C). IL-12 p40 protein expression was
augmented in colonic explant cultures from transitioned Il10−/− mice compared to WT mice
(Supplemental Figure 2A). Likewise, Il12b and Tnf expression was increased in Il10−/− but
not WT colonic tissue (Supplemental Figure 2B–C).
Nuclear factor, erythroid 2 related factor 2 (Nrf2), a basic region leucine zipper transcription
factor, is activated during cellular stress and inflammation, and is largely responsible for
activation of Hmox1 transcription7. To determine whether Nrf2 is involved in transcriptional
regulation of colonic stress response genes induced by the microbiota, expression of Nrf2
regulated genes (Hmox1, Nqo1, Gclc, Fth1, Txnrd1)8 was determined in GF and
conventionally raised WT and Il10−/− mice. Significantly higher induction of Nrf2 regulated
genes was observed in WT CNV mice compared to GF mice (Figure 1D), implicating Nrf2
as a homeostatic regulator of colonic Hmox1 induction by the microbiota. Consequently,
attenuated induction of Nrf2 regulated genes was found in Il10−/− CNV compared to GF
mice (Figure 1D).
We have previously shown that TLR ligands induce Hmox1 expression in bone marrow-
derived macrophages (BMDMs) in a MyD88 dependent manner6. Moreover, IL-10 is a
cofactor for HO-1 induction by TLR ligands through MyD88 independent mechanisms6,
consistent with attenuated colonic Hmox1 induction by the microbiota in Il10−/− mice
(Figure 1A, B, D). To advance these observations, Hmox1 and IL-10 expression was
evaluated in colonic CD11b+ lamina propria mononuclear cells (LPMC) from WT mice and
mice deficient in the downstream TLR signaling molecules MyD88 and TRIF. Interestingly,
Hmox1 expression was similar in CD11b+ LPMC from MyD88−/− mice and WT mice
(Figure 1E), demonstrating MyD88 independent mechanisms of Hmox1 regulation. Notably,
in Trif−/− CD11b+ LPMC, there was increased expression of Hmox1 (Figure 1E) and IL-10
(Figure 1F), compared to CD11b+ cells from MyD88−/− and WT mice, suggesting that TRIF
is a negative regulator of the mutually dependent homeostatic IL-10 and Hmox1 pathways6.
HO-1 induction by the microbiota is conserved in vertebrates
If HO-1 plays a prominent homeostatic role in the intestinal immune system, we reasoned
that Hmox1 induction by the enteric microbiota would be conserved among vertebrate hosts.
To test this hypothesis, hmox1 transcript levels were measured in gnotobiotic zebrafish
larvae at 6 days post-fertilization (dpf) after rearing them under GF conditions or colonizing
with a conventional microbiota at 3 dpf (conventionalized, CNV). Significantly increased
expression of hmox1 was observed in CNV zebrafish relative to GF controls (Figure 2A).
Next, zebrafish embryos were injected with nrf2 morpholino (MO) oligonucleotides to
inhibit Nrf2 translation or a standard control MO, and then reared under GF or CNV
conditions until 6 dpf. The efficiency of nrf2 MO knockdown was confirmed by reduced
transcript levels of the known Nrf2 target gene, glutathione S-transferase pi (gstp1)9 (Figure
2B). Induction of hmox1 expression in CNV zebrafish injected with nrf2 MO was
significantly diminished relative to those injected with standard control MO, indicating that
hmox1 induction by the microbiota is nrf2 dependent in zebrafish, (Figure 2A).
Pharmacologic induction of HO-1 attenuates microbiota-induced colitis in Il10−/− mice
Induction of colonic HO-1 by the microbiota correlated with protection from colitis in GF to
SPF transitioned WT mice. If protection from colitis development is secondary to HO-1
activity, then pharmacologic induction of HO-1 in GF Il10−/− mice should attenuate colitis
development induced by microbiota conventionalization. To test this hypothesis, GF Il10−/−
mice were administered cobalt protoporphyrin (CoPP), an inducer of HO-1, or vehicle
(DMSO) intraperitoneally (IP), every other day for one week prior to SPF transition (Figure
3A). CoPP treated GF Il10−/− mice demonstrated a robust increase in colonic HO-1 protein
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compared with vehicle treated mice (Figure 3B). Moreover, CoPP treated Il10−/− mice
demonstrated attenuated colitis (Figure 3C) and decreased IL-12 p40 secretion in colonic
explant cultures (Figure 3D) compared to the vehicle treated group.
CoPP and ALF186 increase intestinal bacterial clearance in Il10−/− mice
We have previously shown that inhaled CO ameliorates chronic colitis in Il10−/− mice with
induction of HO-1 necessary for protection5. The CO releasing molecule (CO-RM) ALF186
is a member of a family of related compounds where CO is covalently bound to a transition
metal and released in aqueous solution10. To validate that ALF186 has similar effects as
inhaled CO in Il10−/− mice, SPF-raised Il10−/− mice (5–6 weeks of age) were given the
cyclooxygenase inhibitor piroxicam for 14 days in the diet to accelerate the development
and severity of chronic colitis11. Following piroxicam treatment, ALF186 or inactive
(i)ALF186 was administered IP twice daily for 2 weeks. ALF186 treated mice displayed a
significant decrease in colitis severity scores (Supplemental Figure 3A) and less colonic
secretion of IL-12 p40 in colon explant cultures (Supplemental Figure 3B) compared with
mice treated with inactivated (i)ALF186 mice.
CO augments clearance of gram positive bacteria in polymicrobial sepsis, while blockade of
HO-1 inhibited bactericidal activity in a S. typhimurium peritonitis model12, 13. We
therefore hypothesized that HO-1 and CO may ameliorate colitis in part by augmenting
clearance of enteric microbes that breach the epithelial barrier. The abundance of bacterial
DNA in mesenteric lymph nodes (MLNs) of Il10−/− mice was measured as a marker of
intestinal bacterial clearance. Eight week old Il10−/− mice were treated with CoPP, ALF186
or PBS by IP injection every 48 hours for two weeks and bacterial DNA abundance in
MLNs quantitated by RT-PCR using universal bacterial 16S rRNA primers. There was
significantly less bacterial DNA in CoPP and ALF186 treated mice compared to PBS
controls (Figure 4A). The integrity of the intestinal epithelial barrier affects bacterial
translocation, so proximal colon epithelial permeability from in vivo experiments was
evaluated by measuring FITC-dextran permeability in colonic tissues mounted on Ussing
chambers. There was an increase in the permeability of FITC-dextran in ALF186 and CoPP
treated groups (Figure 4B). This result suggests that reduced bacterial detection in MLNs of
ALF186 and CoPP treated Il10−/− mice was not secondary to increased intestinal epithelial
barrier integrity. Additionally, CoPP and ALF186 did not inhibit enteric bacterial growth in
culture (Supplemental Figure 4).
Induction of HO-1 augments S. typhimurium clearance in an infectious colitis model
To further substantiate these observations, an enteric bacterial infection model (S.
typhimurium) in WT mice that is characterized by invasion of mucosal and systemic
lymphoid structures was utilized14. Significant reductions in live bacteria were noted in
lamina propria, MLN, liver and spleen homogenates of CoPP treated mice relative to PBS
controls (Figure 5A-D). S. typhimurium recovery from feces was not statistically different
between groups (Figure 5E) and CoPP did not inhibit S. typhimurium growth in culture
(Supplemental Figure 4C), suggesting that differences in mucosal and systemic bacterial
recovery was not a consequence of differences in luminal bacterial abundance and/or
growth. Moreover, there was no difference in FITC-dextran permeability between groups
(Figure 5F) indicating that reduced systemic bacterial abundance in CoPP treated mice was
not secondary to increased epithelial barrier integrity.
HO-1 derived CO enhances macrophage bactericidal activity
Based on our in vivo findings, we speculated that CO and HO-1 induction may enhance the
ability of macrophages to eradicate enteric bacteria. WT BMDMs were transfected with
Hmox1 siRNA and demonstrated significant knockdown of HO-1 compared with control
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scrambled siRNA transfected BMDMs (Figure 6A). Hmox1 siRNA transfected BMDMs
showed impaired killing of intracellular K12 E. coli, E. faecalis and S. typhimurium (Figure
6B, C and D) compared with scrambled siRNA transfected BMDMs. The RAW 264.7
macrophage cell line stably transfected to over-express HO-1 demonstrated enhanced E. coli
clearance compared with control plasmid transfected cells (Figure 6E). To demonstrate
whether HO-1 derived CO is a downstream mediator of bactericidal activity, Hmox1 siRNA
and control transfected BMDMs were incubated with ALF186 or iALF186. Incubation with
ALF186 enhanced macrophage bactericidal activity in control and Hmox1 siRNA
transfected cells compared to iALF186 treated BMDMs (Figure 6B–D, black bars). ALF186
but not iALF186 resulted in restitution of bactericidal activity in Hmox1 siRNA transfected
macrophages exposed to E. coli, E. faecalis or S. typhimurium. ALF186 and iALF186 had
no effect on BMDM viability (Supplemental Figure 5A). Additionally, similar levels of
phagocytosis were observed in Hmox1 siRNA transfected BMDMs versus scrambled
siRNA BMDMs and ALF186 versus iALF186 treated BMDMs (Supplemental Figure 5B–
C).
We next sought to determine if treatment with ALF186 affects phagolysosomal maturation
in macrophages as a mechanism for enhanced bactericidal activity. ALF186 and iALF186
treated WT BMDMs were incubated with medium containing LysoTracker® Red DND-99,
a weak base that permeates cell membranes and fluoresces upon protonation in low-pH
environments. ALF186-treated BMDMs demonstrated a significantly increased percentage
of LysoTracker®-positive cells when cultured with E. coli (Figure 6F), suggesting that
HO-1 derived CO may enhance phagolysosomal formation/acidification. E. coli labeled with
eGFP was ultilized to localize bacteria to phagolysosomes (representative photomicrograph
shown with LysoTracker staining in Supplemental Figure 5D).
DISCUSSION
The dynamic balance between the enteric microbiota and host innate responses in the
intestine plays a pivotal role in the pathogenesis of IBD. Disordered homeostatic
mechanisms such as autophagy, intracellular microbial killing, and cytokine expression have
been implicated in disrupting this balance15. Utilizing GF WT and Il10−/− mice, this study
demonstrates that the enteric microbiota regulate expression of HO-1 in mice and zebrafish,
and that HO-1 induction inversely correlates with colonic inflammation in Il10−/− mice.
Induction of colonic IL-10 has previously been shown to be dependent on the presence of
enteric microbiota, with macrophages and regulatory T cells as primary sources16. We have
previously demonstrated that HO-1 is induced by TLR ligands in BMDMs in an IL-10 and
MyD88 dependent manner6. However, the present findings describe unique mechanisms of
Hmox1 regulation in colonic macrophages. Increased levels of Hmox1 and IL-10 were
found in Trif−/− mice compared with WT and MyD88−/− mice (Figure 1E, F). This result is
consistent with our previous report where Trif was identified as a negative regulator of
IL-10 in CD11b+ LPMC17. However, unlike BMDMs where Hmox1 induction is MyD88
dependent6, in CD11b+ LPMC, Hmox1 is induced in vivo through MyD88 independent and
IL-10 dependent pathways.
Consequently, we used Il10−/− mice to elucidate functional effects of HO-1 and CO on
clearance of commensal bacteria. Treatment of Il10−/− mice with ALF186 or CoPP was
associated with increased enteric bacterial clearance in intestinal secondary lymphoid tissue.
Increased intestinal permeability defects, modulated by the enteric microbiota, precede the
development of colitis in Il10−/− mice18. In this study, enhanced intestinal barrier function
was not responsible for reduced extraluminal bacterial detection, which instead implicates
host clearance mechanisms. Moreover, CoPP and ALF186 did not exhibit direct
antibacterial properties.
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Differences in bacterial recovery at extraluminal sites between experimental groups may be
a secondary consequence of differences in the intestinal inflammatory state. To mitigate this
confounding issue in the assessment of bacterial clearance, we studied Il10−/− mice at a
young age (eight weeks) when colitis is mild to assess bacterial clearance in a model that
wouldn’t be biased by major differences in histologic inflammation between treatment
groups. Indeed, significant differences in colonic inflammation were not detected between
treatment groups (Supplemental Figure 6A). Likewise, an early time-point was chosen to
evaluate bacterial clearance in the S. typhimurium model to exclude differences in bacterial
recovery as a consequence of differences in inflammation and cellular infiltration
(Supplemental Figure 6B). Early control of intracellular S. typhimurium infection is
dependent on professional phagocytes. Macrophages are the main harbor of this intracellular
pathogen in vivo19. S. typhimurium has also been shown to disrupt epithelial barrier
integrity20. Consequently, this infectious model of colitis presents a more direct measure of
bacterial clearance in vivo and allows correlation with our cell-based findings of HO-1
augmented bactericidal activity in macrophages. In summary, our studies show that
induction of HO-1 leads to augmented clearance of bacteria from secondary mucosal
lymphoid and systemic sites in two colitis models.
We previously demonstrated that CO ameliorates chronic inflammation through HO-1
dependent mechanisms in Il10−/− mice5. We have more recently shown different anti-
inflammatory mechanisms of CO and HO-1 in TCRα−/− mice, where amelioration of colitis
by CO and HO-1 induction was associated with increased IL-10 and IL-22 production, and
decreased Th2 cytokine expression6. These studies demonstrate pleiotropic effects of the
HO-1 pathway in different models of microbiota dependent colitis and combined with our
current findings, suggest that the HO-1 pathway affects multiple central homeostatic
processes. Moreover, we observed a similar phenomenon in GF zebrafish transitioned to a
conventional microbiota, suggesting that HO-1 is important across diverse vertebrate
lineages. Nrf2 is a well described transcriptional factor responsible for HO-1 induction in
mammals and zebrafish in response to oxidative stress7. Here, we show that Nrf2 is
responsible for HO-1 induction by the microbiota in mice and zebrafish. Moreover,
decreased induction of Nrf2 inducible genes in Il10−/− GF mice colonized with microbiota,
compared to WT mice suggests a key homeostatic interrelated regulatory pathway involving
IL-10, Nrf2, and HO-1 in the intestine (Figure 1D).
This study also reveals mechanisms through which HO-1 and CO affect macrophage
bactericidal activity. The importance of microbicidal pathways in the pathogenesis of IBD is
highlighted by the discovery that synonymous SNPs in the autophagocytic genes ATG16L1
and IRGM; and a SNP in the phagosomal gene NCF4 are associated with enhanced risk for
IBD21, 22. Incubation with ALF186 resulted in significantly increased phagolysosomal
formation/activation in macrophages associated with enhanced killing of intracellular E.
coli, E. faecalis and S. typhimurium. Chung and colleagues recently demonstrated that a
CO-RM increases phagocytosis, decreases circulating bacterial counts and rescues
Hmox1−/− mice from mortality in polymicrobial sepsis, interestingly via mechanisms that
involve the Crohn’s disease susceptibility gene product NOD212. Our studies show similar
effects between HO-1 induction and CO release implicating CO as a downstream effector of
HO-1. Similarly, Otterbein and colleagues have shown in vitro that CO increased
macrophage phagocytosis of E. coli23. However, we did not observe increased phagocytosis
in cells, possibly due to differences in cell types and CO-RMs used in the respective
experiments. Other interrelated mechanisms through which HO-1 promotes homeostasis are
possible. Induction of HO-1 may foster the development of a microbiota that sustains
colonic HO-1 expression and ameliorates inflammation. Likewise, HO-1 may induce the
expression of unidentified cytokines/growth factors that directly mediate homeostasis.
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In conclusion, the enteric microbiota induce colonic HO-1 in WT but not colitis-prone
Il10−/− mice. HO-1 and its metabolic product CO exert their anti-inflammatory effects in
part through enhancement of macrophage bactericidal activity. Consequently, defective
HO-1 induction in macrophages may lead to defective clearance of enteric bacteria,
contributing to the pathogenesis of IBD.
MATERIALS AND METHODS
Reagents
Cobalt(III) protoporphyrin IX chloride (CoPP) was from Frontier Scientific. ALF186, a CO-
RM with structure [Mo(CO)3(histidinato)]Na, was obtained from Alfama, Inc (Lisbon,
Portugal). ALF186 is water soluble and stable under anaerobic conditions but releases CO in
a pH dependent fashion under aqueous aerobic conditions with a half-life of ~30 minutes. In
vivo, peak carboxyhemoglobin levels are seen in 5–10 minutes after intraperitoneal,
intravenous and oral administration (data not shown). On completion of in vivo experiments,
blood carboxyhemoglobin levels of 10% to 12% were detected in individual mice, consistent
with previously reported results in mice exposed to CO in ambient air5. A RAW 264.7 cell
line stably transfected to overexpress HO-1 was generated by L. Otterbein. Bacterial strains
used were E. coli K12 strain ATCC 29181, S. typhimurium strain ATCC 14028, E. faecalis
OG1RF and streptomycin resistant S. typhimurium strain CA32.
Mice
All animals were housed in accordance with guidelines from the American Association for
Laboratory Animal Care and Research Protocols and experiments were approved by the
Institutional Animal Care and Use Committee of the University of North Carolina. WT,
Il10−/− MyD88−/−, and Trif−/− mice in SPF housing were on the C57BL/6 background and
matched for age in all experiments. 129S6/SvEv germ free (GF) mice (WT and Il10−/−) were
derived and maintained by standard techniques24 at the University of North Carolina
Gnotobiotic Facility.
Il10−/− colitis model
GF to CNV transition: 129S6/SvEv GF Il10−/− mice were colonized at 10–12 weeks of age
with an enteric microbiota isolated from 129S6/SvEv WT mice raised in SPF conditions25.
In other experiments, GF Il10−/− mice were injected IP with 5 mg/kg of CoPP every 48
hours for 7 days then transitioned to SPF microbiota. Bacterial translocation: SPF raised
C57Bl/6 Il10−/− mice were injected IP with either PBS or 5 mg/kg CoPP every 48 hours for
14 days. Mice were euthanized at day 14, MLNs were harvested and total DNA recovered
for measurement of bacterial 16S rRNA gene copies by real-time PCR. Piroxicam model: 5–
6 week old C57Bl/6 Il10−/− mice raised in SPF conditions were fed piroxicam chow for 2
weeks as described5. Mice were subsequently injected IP with 30 mg/kg of ALF186 or
inactive ALF186, every 48 hours for two weeks.
S. typhimurium colitis model
WT C57Bl/6 mice housed in SPF conditions were infected with S. typhimurium as
described with modifications14. Mice were pretreated with streptomycin by oral gavage and
12 hours later were treated with 5 mg/kg CoPP via IP injection or 100 μl of PBS (vehicle).
12 hours following, streptomycin resistant S. typhimurium (108 CFU) was introduced by
oral gavage. CoPP or PBS treatment was repeated 48 hours later. Mice were euthanized 72
hours after infection. Organs were recovered under sterile conditions and homogenized
using a rotor homogenizer. Cecal tissue was thoroughly washed in sterile PBS prior to
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homogenization. Dilutions in sterile PBS were plated on LB agar with 50 μg/ml
streptomycin to determine CFUs.
Permeability Assay
Segments of proximal colon were harvested, placed in oxygenated (95% O2-5% CO2)
Ringer solution and tissues were then mounted in 0.3 cm2 aperture Ussing chambers
(Physiologic Instruments, San Diego, CA) as previously described 26, 27. Mucosal-to-serosal
flux of (FITC)-dextran (4 kDa; Sigma-Aldrich, St. Louis, MO) (FD4) was performed as
described28. The presence of FD4 fluorescence intensity was measured by fMax
Fluorescence Microplate Reader (Molecular Devices, Sunnyvale, CA) and concentrations
were determined from standard curves generated by serial dilution of FD4. Data for FD4
flux are presented as μg FD4/cm2.min.
Zebrafish
Zebrafish (Danio rerio) embryos were derived into GF conditions using published
methods 29. GF embryos were either maintained under GF conditions until 6 dpf or
inoculated with a conventional zebrafish microbiota at 3 dpf. GF and CNV zebrafish were
provided an autoclaved diet (ZM-000, ZM Ltd) beginning 3 dpf. Zebrafish embryos were
injected with nrf2/nfe2l2 morpholino (nfe2l2.e1.ATG, 2.5 pmol/embryo;
CATTTCAATCTCCATCATGTCTCAG; Entrez Gene ID 360149) or standard control
morpholino oligonucleotides (Gene Tools LLC) as previously described30. At 6 dpf, total
RNA from whole zebrafish was harvested from pools of GF and CNV larvae (5–10 larvae/
pool, 2 biological replicate pools/condition), and transcript levels for hmox1 and gstp1 were
evaluated by real-time RT-PCR and normalized to rpl32 levels as described30.
Bone marrow-derived macrophages
BMDMs were cultured as described31.
Cytokine ELISAs
Murine IL-12 p40 and TNF ELISA kits (R&D Systems) was used according to
manufacturers’ instructions.
Western immunoblot
Western immunoblot analyses were performed on whole cell extracts as described31. Anti–
HO-1 antibodies were from Stressgen and β-actin antibodies were purchased from Abcam,
MA.
Real time RT-PCR
Real time RT-PCR was performed as described6. Primer sequences are listed in
Supplemental Table 1.
siRNA transfection
BMDMs were transfected with ON-TARGETplus Hmox1 siRNA, Chicago, IL using
AMAXA Nucleofector Technology (AMAXA) by the protocol for murine macrophages.
Control scrambled siRNA was purchased from Dharmacon, IL.
Colonic tissue explant cultures
Sections of colon were processed as described5.
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Colitis scoring from colonic tissue sections from Il10−/− mice was performed as described5.
In the S. typhimurium model, histological inflammation was assessed using a previously
reported scoring system14. All histological scores were determined by a veterinary
pathologist (LBB) blinded to the experimental treatment groups.
Bacterial DNA Isolation
Total DNA was extracted from mesenteric lymph nodes as described32. Bacterial 16S rRNA
gene copies were determined by real-time RT-PCR using universal bacterial primer
sequences (Supplemental Table 1) and normalized to total DNA33.
Gentamicin protection assay
1×106 WT and Il10−/− BMDMs were cultured in 12-well plates in triplicate and incubated
with E. coli, E. faecalis or S. typhimurium at 10:1 ratio in antibiotic-free medium for 1 hour.
Cells were then washed with PBS plus gentamicin (200 μg/ml) and incubated in medium
supplemented with gentamicin (200 μg/ml) at 37°C for an additional hour to eliminate
extracellular bacteria. New medium supplemented with gentamicin (100 μg/ml) was added
to cells. ALF186 (100 μg/ml) and iALF186 (100 μg/ml) were added to the cells after
elimination of extracellular bacteria. Cells were lysed with 1% Triton X-100, diluted, plated
on BHI agar plates, and incubated at 37°C. CFUs calculated at 1 hour reflected the total
uptake of bacteria (phagocytosis). CFUs recovered at 12 hours are represented as the percent
survival of total bacteria phagocytosed at the 1 hour time point.
Phagolysosomal acidification assay
BMDMs from WT mice were incubated with ALF186 (100 μM) or iALF186 (100 μM), for
1 hour. Cells were then treated with LysoTracker® Red DND-99 (Invitrogen) 100 nM for 30
mins and E. coli K12 for 1h, fixed in 4% paraformaldehyde and stained with nuclear stain
Topro-3, 5 nM (Invitrogen). E. coli labeled with eGFP (to localize bacteria to
phagolysosomes) was used as a positive control. Cells were visualized using confocal
microscopy with a Carl Zeiss LSM 710 laser scanning microscope. At least 10 high powered
fields and 100 cells were counted.
Statistical Analysis
Statistical significance for data subsets from experiments performed in cells was assessed by
the two-tailed Student’s t-test. Statistical significance for in vivo data subsets was assessed
by the Mann-Whitney U test (SPSS, Chicago, IL, USA) with Bonferroni correction or one-
way ANOVA where appropriate. A value of p < .05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ALF186 Alfama CO-releasing molecule 186
BMDMs bone marrow derived macrophages
CO carbon monoxide
CoPP cobalt protoporphyrin
CFU colony forming unit
ELISA enzyme-linked immunosorbant assay
Fth1 ferritin, heavy polypeptide 1
GF germ-free
Gclc glutamate-cysteine ligase, catalytic subunit






Il10 murine IL-10 gene
Nqo1 NAD(P)H:quinone oxidoreductase
Nrf2 NF-E2-related factor 2
PCR polymerase chain reaction
SPF specific pathogen freeIl10−/−
TCRα−/− T cell receptor- alpha deficient mice
Th T-helper cell
Txnrd1 thioredoxin reductase 1
WT wild-type
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Figure 1. The enteric microbiota regulate colonic Hmox1 expression through Nrf2 and TLR
dependent pathways
WT (n = 3) and Il10−/− mice (n = 3) in GF conditions were conventionalized (CNV) with
SPF enteric microbiota at 8 weeks of age. (A) Total RNA was isolated 14 days post-CNV
and Hmox1 mRNA detected by real-time RT-PCR. Error bars represent mean ± SEM of
three mouse colons analyzed independently. *p < .05 versus WT GF mice. (B) Total colonic
protein was isolated and analyzed for HO-1 expression by Western blot. Data are
representative of three independent blots on individual mouse colons. (C) Colitis scores of
8-week-old GF and CNV WT and Il10−/− mice represent mean ± SEM from three individual
mouse colons. *p < .05, **p < .01 versus WT GF mice. (D) Total colonic RNA was isolated
from WT (7 mice/group) and Il10−/− (7 mice/group) mice raised either GF or 14 days post-
CNV. Expression of Nrf2 inducible genes (Hmox1, Nqo1, Gclc, Fth1, Txnrd1) were
detected by real-time RT-PCR (normalized to β-actin mRNA). Results are from two
independent experiments, presented as fold change of CNV mice relative to GF baseline
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controls. *p < .05, **p < .005. (E) Hmox1 expression was detected by real-time RT-PCR.
Data represent mean ± SEM from 2 independent experiments with 3 mice per group,
presented as fold change of CNV mice relative to GF baseline controls (normalized to β-
actin mRNA). (F) Colonic CD11b+ LPMCs were isolated from WT, MyD88−/−, and Trif−/−
mice. IL-10 secretion was determined by ELISA. Data represents mean ± SEM from 2
independent experiments with 3 mice per group. *p < .05.
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Figure 2. HO-1 induction by the microbiota is conserved in vertebrates and regulated by nrf2
Zebrafish embryos derived in GF conditions were either transitioned to conventional
microbiota (CNV) at 3 days post fertilization (dpf) or maintained GF. Total RNA isolated
from zebrafish larvae at 6 dpf was analyzed for hmox1 expression by real-time RT-PCR. (A)
Zebrafish embryos were injected with nrf2 morpholino (MO) to knockdown nrf2 mRNA
translation, or standard control MO, then derived into GF conditions. At 3 dpf, zebrafish
were transitioned to conventional microbiota or maintained GF. At 6 dpf, hmox1 expression
was again analyzed by real-time RT-PCR. (B) Results of gstp1 expression in nrf2 MO and
control MO treated zebrafish are shown as a positive control. Data represent mean ± SEM of
biological duplicate pools (5–10 larvae/pool, 2 pools/condition) normalized to rpl32 mRNA
levels.
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Figure 3. Pharmacologic HO-1 induction prevents enteric microbiota induced colitis in Il10−/−
mice
(A) GF Il10−/− mice were injected IP with 5 mg/kg CoPP (n = 4) or DMSO (vehicle, n = 4)
every 48 h for 7 days, then conventionalized for 14 days. (B) Western blot on colonic tissue
from 2 GF mice after 7 days of CoPP administration. (C) At 14 days after CNV, colitis
scores were determined in CoPP injected mice and compared with DMSO injected mice.
Results are presented as the mean of four averaged scores from five regions of the large
intestine. Bars represent mean ± SEM (4 mice/group). (D) Spontaneous IL-12 p40 secretion
was determined by ELISA in 24 hour supernatants from colonic explants from CoPP and
DMSO treated Il10−/− mice. Results represent mean ± SEM from three independent colonic
explant cultures (n = 3 mice/group). *p < .05, versus DMSO (vehicle) injected mice.
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Figure 4. CoPP and ALF186 enhance intestinal bacterial clearance in Il10−/− mice
(A) Il10−/− mice (8–12 weeks old) were injected IP with 5mg/kg CoPP (n = 14), 30 mg/kg
ALF186 (n = 14) or PBS control (n = 7), every 48 h for 14 days. Total DNA was isolated
from MLNs and bacterial 16S rRNA gene copies were determined by real-time RT-PCR.
Data are presented as combined mean ± SEM from three independent experiments. (B)
Permeability was analyzed in proximal colon tissue in Ussing chambers by measuring
mucosal-to-serosal FITC-dextran flux. Data represent mean ± SEM from duplicate
experiments with n ≥ 4 per group. *p < .05 compared with PBS control.
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Figure 5. Pharmacologic HO-1 induction enhances S. typhimurium clearance in WT mice
(A–E)Streptomycin treated WT mice were injected IP with CoPP (n = 5) or PBS (n = 4), 12
h prior to oral gavage with streptomycin resistant S. typhimurium. Treatment was repeated
48 h later and mice were euthanized 72 h after infection. Organs were recovered and CFUs
were quantified by plating on LB agar with 50 μg/mL streptomycin. Data are presented as
mean ± SEM and are representative of two independent experiments with similar results. (F)
Permeability was analyzed in proximal colon tissue in Ussing chambers by measuring
mucosal-to-serosal FITC-dextran flux. Data are presented as mean ± SEM. *p < .05, **p < .
01.
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Figure 6. HO-1 and CO enhance macrophage bactericidal activity
(A) siRNA was used to knock down Hmox1 in WT BMDMs. Total protein was isolated and
analyzed for HO-1 expression by Western blot to assess gene silencing. BMDMs were
analyzed for macrophage bactericidal activity against (B) E. coli (C) E. faecalis and (D) S.
typhimurium using gentamicin protection assay. siRNA transfected cells were also cultured
in the presence of ALF186 (black bars) or inactive iALF186 (white bars) to study the effect
of CO on bactericidal activity. Data are presented as mean ± SEM of 3 independent
experiments. (E) RAW 264.7 macrophages that stably overexpress Hmox1 were used in
gentamicin protection assays against E. coli K12. Results are expressed as mean ± SEM
from 3 independent experiments, *p < .05 vs. scrambled siRNA transfected BMDMs. (F–G)
BMDMs were incubated with ALF186, iALF186 (100 μM), CoPP (10 μM) or DMSO, then
cells were treated with LysoTracker® (100 nM), and exposed to K12 E. coli. Cells were
then fixed and nuclei stained with Topro-3, 5 nM. LysoTracker® positive cells were
calculated as a percentage of total cells. At least 10 high powered fields and at least 100
cells were counted. Data are presented as mean ± SEM of 3 independent experiments. *p < .
05.
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